Literature DB >> 25521438

Colorectal Cancer Screening and State Health Insurance Mandates.

Mary K Hamman1, Kandice A Kapinos2.   

Abstract

Colorectal cancer (CRC) is the third most deadly cancer in the USA. CRC screening is the most effective way to prevent CRC death, but compliance with recommended screenings is very low. In this study, we investigate whether CRC screening behavior changed under state mandated private insurance coverage of CRC screening in a sample of insured adults from the 1997 to 2008 Behavioral Risk Factor Surveillance Survey (BRFSS). We present difference-in-difference-in-differences (DDD) estimates that compare insured individuals age 51 to 64 to Medicare age-eligible individuals (ages 66 to 75) in mandate and non-mandate states over time. Our DDD estimates suggest endoscopic screening among men increased by 2 to 3 percentage points under mandated coverage among 51 to 64 year olds relative to their Medicare age-eligible counterparts. We find no clear evidence of changes in screening behavior among women. DD estimates suggest no evidence of a mandate effect on either type of CRC screening for men or women.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cancer screening; health insurance mandates

Mesh:

Year:  2014        PMID: 25521438     DOI: 10.1002/hec.3132

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  7 in total

1.  Mandated coverage of preventive care and reduction in disparities: evidence from colorectal cancer screening.

Authors:  Mary K Hamman; Kandice A Kapinos
Journal:  Am J Public Health       Date:  2015-04-23       Impact factor: 9.308

2.  Lessons from state mandates of preventive cancer screenings.

Authors:  Wendy Yi Xu; Bryan Dowd; Jean Abraham
Journal:  Eur J Health Econ       Date:  2015-03-15

3.  Changes in screening colonoscopy following Medicare reimbursement and cost-sharing changes.

Authors:  Lina D Song; Joseph P Newhouse; Xabier Garcia-De-Albeniz; John Hsu
Journal:  Health Serv Res       Date:  2019-04-02       Impact factor: 3.402

4.  Value Of Waiving Coinsurance For Colorectal Cancer Screening In Medicare Beneficiaries.

Authors:  Elisabeth F P Peterse; Reinier G S Meester; Andrea Gini; Chyke A Doubeni; Daniel S Anderson; Franklin G Berger; Ann G Zauber; Iris Lansdorp-Vogelaar
Journal:  Health Aff (Millwood)       Date:  2017-12       Impact factor: 6.301

5.  Association between colorectal cancer testing and insurance type: Evidence from the Swiss Health Interview Survey 2012.

Authors:  Alexander Leonhard Braun; Anja Kässner; Lamprini Syrogiannouli; Kevin Selby; Jean-Luc Bulliard; Yonas Martin; Idris Guessous; Kali Tal; Cinzia Del Giovane; Marcel Zwahlen; Reto Auer
Journal:  Prev Med Rep       Date:  2020-05-04

6.  Health Insurance Coverage Mandates: Colorectal Cancer Screening in the Post-ACA Era.

Authors:  Michael A Preston; Levi Ross; Askar Chukmaitov; Sharla A Smith; Michelle L Odlum; Bassam Dahman; Vanessa B Sheppard
Journal:  Cancer Prev Res (Phila)       Date:  2020-09-11

7.  Government regulation of private health insurance.

Authors:  Nkengafac Villyen Motaze; Primus Che Chi; Pierre Ongolo-Zogo; Jean Serge Ndongo; Charles S Wiysonge
Journal:  Cochrane Database Syst Rev       Date:  2021-02-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.